These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28693214)

  • 41. High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma.
    Yangngam S; Thongchot S; Pongpaibul A; Vaeteewoottacharn K; Pinlaor S; Thuwajit P; Okada S; Hermoso MA; Thuwajit C
    J Cancer; 2020; 11(22):6571-6581. PubMed ID: 33046978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma.
    Raunroadroong N; Sriplung H; Lertprasertsuke N; Pojchamarnwiputh S; Chiangmai WN; Sinsuwan W; Thongprasert S
    Hepat Oncol; 2014 Oct; 1(4):377-386. PubMed ID: 30190973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.
    Proungvitaya S; Sombattheera S; Boonsiri P; Limpaiboon T; Wongkham S; Wongkham C; Titapun A; Proungvitaya T
    Oncol Lett; 2017 Oct; 14(4):4943-4948. PubMed ID: 29085505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis.
    Thonsri U; Seubwai W; Waraasawapati S; Sawanyawisuth K; Vaeteewoottacharn K; Boonmars T; Cha'on U
    Histol Histopathol; 2017 May; 32(5):503-510. PubMed ID: 27615379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.
    Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P
    Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms.
    Kimawaha P; Jusakul A; Junsawang P; Thanan R; Titapun A; Khuntikeo N; Techasen A
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33806004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
    Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via
    Yin X; Chai Z; Sun X; Chen J; Wu X; Yang L; Zhou X; Liu F
    Exp Ther Med; 2020 Apr; 19(4):2757-2765. PubMed ID: 32256758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.
    Cheng CT; Chu YY; Yeh CN; Huang SC; Chen MH; Wang SY; Tsai CY; Chiang KC; Chen YY; Ma MC; Liu CT; Chen TW; Yeh TS
    Onco Targets Ther; 2015; 8():1899-907. PubMed ID: 26251613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma.
    Yang JD; Campion MB; Liu MC; Chaiteerakij R; Giama NH; Ahmed Mohammed H; Zhang X; Hu C; Campion VL; Jen J; Venkatesh SK; Halling KC; Kipp BR; Roberts LR
    Hepatology; 2016 Jan; 63(1):148-58. PubMed ID: 26096702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma.
    Loosen SH; Benz F; Niedeggen J; Schmeding M; Schüller F; Koch A; Vucur M; Tacke F; Trautwein C; Roderburg C; Neumann UP; Luedde T
    Clin Transl Med; 2016 Dec; 5(1):39. PubMed ID: 27709523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma.
    Huang DW; Huang M; Lin XS; Huang Q
    Onco Targets Ther; 2017; 10():3817-3825. PubMed ID: 28814880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural History and Prognostic Factors of Cholangiocarcinoma With Spinal Metastasis: A 10-Year Single Center Study.
    Sangsin A; Saiudom D; Pongmanee S; Saengsin J; Leerapun T; Murakami H
    Clin Spine Surg; 2018 Apr; 31(3):E160-E165. PubMed ID: 29596214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.